Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNorthfield Laboratories Announces Decision to Wind Down Business
Northfield Laboratories, 05/18/09
Northfield Laboratories Inc. announced that it has determined to wind down its business operations and carry out an orderly disposition of its assets. Following its review and analysis of the complete response letter received from the Food and Drug Administration on April 2009, Northfield determined that further clinical development of a reformulated version of its PolyHeme human red cell substitute product, including additional clinical trials, would likely be required before it could again seek to obtain FDA approval.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Milatuzumab – a promising new immunotherapeutic agent
Expert Opinion on Investigational Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor